The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
30
No.
01
January 02, 2004
- NCI clinical trials cooperative group chairmen reject specimen bank contract proposal, endorse cooperative agreements;
- Executive Committee, Board of Scientific Advisors concur.
- Also NCI requests $6.2 billion in FY2005 Bypass Budget.
- NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.
- Obituary: Michale Keeling, of M.D. Anderson.
- Funding opportunities listed.
TCL
Vol.
30
No.
02
January 09, 2004
- Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.
- Also NCI appoints members of Clinical Trials Working Group to review trials system.
- Omnibus bill recissions would cut $28 million from NCI FY04 budget.
- Nominations sought for NCI consumer liaison group.
- Ohio State recruits neurosurgeon from Harvard to lead new department.
- Funding opportunities listed.
TCL
Vol.
30
No.
03
January 16, 2004
- Special Report on Cancer Centers: Three cancer centers win $9 million core grants, 11 of 13 competitors cut due to NCI budget shortfall.
- List of core grants renewed in FY 2003, full list of center grants.
- Also C-Change new name for National Dialogue on Cancer.
- Comment period for biospecimen network proposal extended.
- Surgeon General plans new report, database, on tobacco.
- Funding opportunities listed.
TCL
Vol.
30
No.
04
January 23, 2004
- NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.
- Also Senate approves spending bill.
- FASEB urges 10 percent increase for NIH in FY 2005.
- Oncologists lose money administering drugs to Medicare patients, survey finds.
- ASCO to form commission to study tobacco problem.
- Lymphoma Research Foundation names William Hawley president.
- Funding Opportunities: NIH seeks “visionary thinkers” for awards of $2.5 million over five years. NCI RFA available.
TCL
Vol.
30
No.
05
January 30, 2004
- NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.
- Also ASCO to release abstracts to members prior to annual meeting.
- Advisors suggest NCI establish sarcoma research consortium.
- Lung cancer screening trial reaches accrual goal of 50,000.
- Markison leaving Bristol-Myers, two others promoted in reorganization.
- Wilding named director, Univ. of Wisconsin Cancer Center.
- NABCO to close June 30.
- This month’s 8-page Business & Regulatory Report included in this issue.
CCL
Vol.
27
No.
1
January 30, 2004
- New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting
- ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children
- Zevalin Regimen Effective In Mantle Cell Lymphoma
- Fondaparinux Prevents DVT In Acutely III Medical Patients
- Clinical Trials Approved By NCI
TCL
Vol.
30
No.
06
February 06, 2004
- FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat.
- FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.
- Also NIH institute directors earn higher salaries than Vice President Cheney; House subcommittee investigating pay of top NIH officials.
- Bush Administration proposes 2.7 percent increase for NIH in fiscal year 2005; NIH budgets listed by institute.
- HHS plans network of smoking cessation quitlines.
- Funding opportunities listed.
TCL
Vol.
30
No.
07
February 13, 2004
- NCI to hold 5 percent of division budgets in reserve for “strategic priorities.” Competing RPG budgets to be cut 18 percent on average.
- Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.
- To nurture staff, NCI plans an academy.
- NCI document says 2015 goal formed in 2001, long before announcement.
- AACR to honor eight scientists with lecture awards.
- M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.
- NCI to set separate payline for R01s over $700,000.
- Funding opportunities listed.
